We nonetheless compared our data to gene signatures from the other isogenic HNSCC resistant model 1CC8 [10], an independent resistant model to an EGFR inhibitor in NSCLC [38], and human tumor data from HNSCC patients before cetuximab treatment [42]. Here, EGFR is linked to neoplasm.